Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Nur, Erfan  [Clear All Filters]
Journal Article
van Lier YF, de Bree GJ, Jonkers RE, Roelofs JJTH, Berge IJMTen, Rutten CE, Nur E, Kuijpers TW, Hazenberg MD, Zeerleder SS. Allogeneic hematopoietic cell transplantation in the management of GATA2 deficiency and pulmonary alveolar proteinosis. Clin Immunol. 2020:108522.
Aydin M, de Leeuw DC, Rutten CE, Visser OJ, Tang MWai, van Roessel C, Janssen JJW, Biemond BJ, van de Loosdrecht AA, Hazenberg MD, et al. ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non-myeloablative conditioning. Br J Haematol. 2023.
Aydin M, Tang MWai, Wondergem MJ, de Leeuw DC, Wegman JJ, Biemond BJ, van de Donk NWCJ, Zweegman S, Meijer E, Nur E. High-dose melphalan in 1 day versus over 2 days followed by autologous stem cell transplantation as consolidation treatment in patients with multiple myeloma. Br J Haematol. 2021.
Mekelenkamp H, de Vries M, Saalmink I, Nur E, Kerkhoffs J-L, Heijboer H, Cnossen M, Lankester A, Smiers F. Hoping for a normal life: Decision-making on hematopoietic stem cell transplantation by patients with a hemoglobinopathy and their caregivers. Pediatr Blood Cancer. 2023:e30808.
Garrido HMGarcia, Haggenburg S, Schoordijk MCE, Meijer E, Tanck MWT, Hazenberg MD, Rutten CE, de Bree GJ, Nur E, Meek B, et al. Immunogenicity of a 5-dose pneumococcal vaccination schedule following allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2022.
de Jong G, Janssen JJWM, Biemond BJ, Zeerleder SS, Ossenkoppele GJ, Visser O, Nur E, Meijer E, Hazenberg MD. Survival of early post-hematopoietic stem cell transplantation relapse of myeloid malignancies. Eur J Haematol. 2019.